DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,556 | +14.1% | 699,549 | +10.4% | 0.41% | +18.7% |
| Q2 2023 | $152,105 | -6.6% | 633,807 | -2.0% | 0.35% | -12.6% |
| Q1 2023 | $162,915 | -10.4% | 646,415 | -5.6% | 0.40% | -15.7% |
| Q4 2022 | $181,789 | -99.9% | 684,896 | -1.3% | 0.47% | -4.3% |
| Q3 2022 | $179,196,000 | +22.9% | 693,729 | +20.6% | 0.49% | +26.8% |
| Q2 2022 | $145,781,000 | -17.5% | 575,023 | -4.4% | 0.39% | +12.1% |
| Q1 2022 | $176,678,000 | -8.0% | 601,762 | +2.5% | 0.35% | -6.5% |
| Q4 2021 | $191,968,000 | +26.5% | 586,848 | +17.7% | 0.37% | +20.1% |
| Q3 2021 | $151,806,000 | +455.2% | 498,798 | +389.5% | 0.31% | +450.0% |
| Q2 2021 | $27,344,000 | +26.3% | 101,898 | +5.9% | 0.06% | +16.7% |
| Q1 2021 | $21,653,000 | -51.9% | 96,206 | -52.5% | 0.05% | -53.8% |
| Q4 2020 | $45,025,000 | -14.6% | 202,687 | -17.3% | 0.10% | -26.2% |
| Q3 2020 | $52,744,000 | +2.6% | 244,945 | -15.9% | 0.14% | -8.4% |
| Q2 2020 | $51,423,000 | +29.9% | 291,145 | +1.8% | 0.15% | +8.5% |
| Q1 2020 | $39,591,000 | -36.8% | 286,056 | -30.0% | 0.14% | -20.2% |
| Q4 2019 | $62,677,000 | +5.5% | 408,376 | -0.7% | 0.18% | -3.3% |
| Q3 2019 | $59,406,000 | -1.5% | 411,317 | -2.5% | 0.18% | +0.5% |
| Q2 2019 | $60,309,000 | -0.2% | 421,973 | -7.8% | 0.18% | -3.7% |
| Q1 2019 | $60,434,000 | +5.6% | 457,762 | -17.5% | 0.19% | -8.2% |
| Q4 2018 | $57,230,000 | -27.7% | 554,979 | -23.8% | 0.21% | -16.5% |
| Q3 2018 | $79,142,000 | -2.8% | 728,346 | -11.7% | 0.25% | -6.8% |
| Q2 2018 | $81,410,000 | +220.0% | 824,991 | +217.5% | 0.27% | +209.3% |
| Q1 2018 | $25,440,000 | +73.4% | 259,831 | +64.3% | 0.09% | +75.5% |
| Q4 2017 | $14,675,000 | +106.2% | 158,100 | +90.6% | 0.05% | +96.0% |
| Q3 2017 | $7,116,000 | +40.4% | 82,960 | +38.1% | 0.02% | +19.0% |
| Q2 2017 | $5,070,000 | +107.6% | 60,070 | +110.3% | 0.02% | +90.9% |
| Q1 2017 | $2,442,000 | +47.1% | 28,558 | +33.9% | 0.01% | +57.1% |
| Q4 2016 | $1,660,000 | +6.4% | 21,328 | +7.2% | 0.01% | 0.0% |
| Q3 2016 | $1,560,000 | -84.0% | 19,898 | -79.3% | 0.01% | -84.8% |
| Q2 2016 | $9,722,000 | -49.9% | 96,268 | -52.9% | 0.05% | -51.1% |
| Q1 2016 | $19,406,000 | -14.6% | 204,580 | -16.4% | 0.09% | -13.8% |
| Q4 2015 | $22,723,000 | +915.8% | 244,650 | +832.0% | 0.11% | +808.3% |
| Q3 2015 | $2,237,000 | +64.4% | 26,250 | +65.1% | 0.01% | +50.0% |
| Q2 2015 | $1,361,000 | +6.2% | 15,900 | +5.3% | 0.01% | +14.3% |
| Q1 2015 | $1,282,000 | +3.1% | 15,100 | +4.1% | 0.01% | 0.0% |
| Q4 2014 | $1,243,000 | +14.0% | 14,500 | +1.0% | 0.01% | +16.7% |
| Q3 2014 | $1,090,000 | -2.2% | 14,350 | +1.4% | 0.01% | 0.0% |
| Q2 2014 | $1,114,000 | +5.3% | 14,150 | +0.4% | 0.01% | -14.3% |
| Q1 2014 | $1,058,000 | -79.4% | 14,100 | -78.8% | 0.01% | -77.4% |
| Q4 2013 | $5,134,000 | +42.7% | 66,500 | +28.1% | 0.03% | +34.8% |
| Q3 2013 | $3,598,000 | +185.6% | 51,900 | +160.8% | 0.02% | +187.5% |
| Q2 2013 | $1,260,000 | – | 19,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |